4D MOLECULAR THERAPEUTICS IN

Ticker: FDMT CUSIP: 35104E100 Class: Common Stock

Opaleye Management Inc.'s Holding History (CIK: 0001595855)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024

Shares 345,750 Value ($000) $7,257 Avg Close $25.09 Range $20.33 - $31.87

Q1 2024

Shares 344,123 Value ($000) $10,964 Avg Close $25.51 Range $16.64 - $36.25

Q4 2023

Shares 308,500 Value ($000) $6,250 Avg Close $13.16 Range $9.44 - $21.53

Q3 2023

Shares 308,500 Value ($000) $3,927 Avg Close $16.73 Range $12.34 - $20.47

Q2 2023

Shares 221,700 Value ($000) $4,006 Avg Close $18.41 Range $13.26 - $24.10

Q1 2023

Shares 314,000 Value ($000) $5,398 Avg Close $19.45 Range $14.67 - $23.81

Q4 2022

Shares 330,000 Value ($000) $7,329 Avg Close $15.45 Range $6.58 - $26.49

Q3 2022

Shares 350,700 Value ($000) $2,820 Avg Close $9.06 Range $6.70 - $11.95

Q2 2022

Shares 325,000 Value ($000) $2,269 Avg Close $9.72 Range $5.32 - $16.39

Q1 2022

Shares 325,000 Value ($000) $4,914 Avg Close $15.70 Range $12.84 - $24.38

Q4 2021

Shares 229,000 Value ($000) $5,024 Avg Close $24.51 Range $18.57 - $34.00

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2024	345,750	$7,257	$25.09	$20.33 - $31.87
Q1 2024	344,123	$10,964	$25.51	$16.64 - $36.25
Q4 2023	308,500	$6,250	$13.16	$9.44 - $21.53
Q3 2023	308,500	$3,927	$16.73	$12.34 - $20.47
Q2 2023	221,700	$4,006	$18.41	$13.26 - $24.10
Q1 2023	314,000	$5,398	$19.45	$14.67 - $23.81
Q4 2022	330,000	$7,329	$15.45	$6.58 - $26.49
Q3 2022	350,700	$2,820	$9.06	$6.70 - $11.95
Q2 2022	325,000	$2,269	$9.72	$5.32 - $16.39
Q1 2022	325,000	$4,914	$15.70	$12.84 - $24.38
Q4 2021	229,000	$5,024	$24.51	$18.57 - $34.00